The IHC results indicated widespread infiltration of CD16+ cells, with greater quantities of CD16+ cells observed in the remaining tumor tissues from the NICT group compared with the NCT group (Supplementary Figure S5B). The gene discussed is FCGR3A; the disease is neoplasm.